Nanomedicine News

RSS
Controlled Positioning of Nucleic Acids on Gold Nanoparticles Creates New Possibilities for Bottom-Up Nanotechnology

Controlled Positioning of Nucleic Acids on Gold Nanoparticles Creates New Possibilities for Bottom-Up Nanotechnology

Nanotherapeutics Announces NanoBUP Demonstrate Strong Oral Absorption in Phase Ia Clinical Trial

Researchers Redefining What's Possible in Medical Diagnostics and Life Sciences

Researchers Redefining What's Possible in Medical Diagnostics and Life Sciences

Innovative Approach for Studying the Forces that Shape Proteins

New Toolbox for Building Nanoscale Structures out of DNA

New Toolbox for Building Nanoscale Structures out of DNA

Nanotechnology Innovations in Health and Safety Applications

Nanotechnology Innovations in Health and Safety Applications

Researchers Assemble New Cancer Drug Delivery System

Researchers Assemble New Cancer Drug Delivery System

Parabon NanoLabs Co-Founder Receives Presidential Early Career Award for Scientists and Engineers

Parabon NanoLabs Co-Founder Receives Presidential Early Career Award for Scientists and Engineers

Biotechnology Company Acquires Full Rights to RenaZorb for All Human and Non-Human Indications

Biotechnology Company Acquires Full Rights to RenaZorb for All Human and Non-Human Indications

Altair Nanotechnologies Assigns Ownership of All Patent Rights to Spectrum Pharmaceuticals

Altair Nanotechnologies Assigns Ownership of All Patent Rights to Spectrum Pharmaceuticals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.